Drug Trial Radar · NCT07216560
First-in-human Study of 7MW4911 in GI Cancer
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Jan 13, 2026
Primary completion
Jul 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is the first-in-human study of 7MW4911 in US patients, to investigate its prelimary safety and efficacy in patients with gastrointestinal cancers.
Conditions
- GI Cancers
Interventions
7MW4911Drug
study drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and rates of adverse eventsTime frame: Up to approximately 2 years
- MTD, RED, and RP2DTime frame: Up to approximately 2 years
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Hematology Oncology Associates of the Treasure Coast
Port Saint Lucie, Florida · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
START
Long Island City, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
START Moutain Region
West Valley City, Utah · Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.